Mounjaro
The brand name for tirzepatide injection approved by the FDA in 2022 for type 2 diabetes management. The diabetes-focused formulation of the same drug sold as Zepbound for weight loss.
What does Mounjaro mean in peptide research?
The brand name for tirzepatide injection approved by the FDA in 2022 for type 2 diabetes management. The diabetes-focused formulation of the same drug sold as Zepbound for weight loss. This term is part of the broader field of peptide research, which encompasses both FDA-approved therapeutic peptides and research-grade compounds used in scientific investigation.
Why this term matters
Understanding Mounjaro is foundational for anyone reviewing peptide research literature, comparing different research compounds, or following regulatory developments in this field. The term appears across pharmacology textbooks, FDA documentation, and clinical trial reports.
Where to learn more
For deeper context, see our peptide research articles: